capecitabine has been researched along with naphthoquinones in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Guzin, G; Yucel, I | 1 |
| Ilyas, S; Saif, MW; Wasif, K | 1 |
| Astras, G; Charalambous, A; Paikousis, L; Stavrinou, M; Tsitsi, T | 1 |
1 trial(s) available for capecitabine and naphthoquinones
| Article | Year |
|---|---|
A randomised controlled feasibility trial to evaluate Lawsonia inermis (henna)'s effect on palmar-plantar erythrodysesthesia induced by capecitabine or pegylated liposomal doxorubicin.
Topics: Adult; Aged; Capecitabine; Doxorubicin; Drug Interactions; Feasibility Studies; Female; Hand-Foot Syndrome; Humans; Male; Middle Aged; Naphthoquinones; Polyethylene Glycols; Treatment Outcome | 2021 |
2 other study(ies) available for capecitabine and naphthoquinones
| Article | Year |
|---|---|
Topical henna for capecitabine induced hand-foot syndrome.
Topics: Administration, Cutaneous; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Female; Fluorouracil; Foot Dermatoses; Hand Dermatoses; Humans; Middle Aged; Naphthoquinones; Neoplasms; Paresthesia; Severity of Illness Index; Syndrome; Treatment Outcome | 2008 |
Topical henna ameliorated capecitabine-induced hand-foot syndrome.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Capecitabine; Deoxycytidine; Female; Fluorouracil; Hand-Foot Syndrome; Humans; Middle Aged; Naphthoquinones; Pancreatic Neoplasms | 2014 |